Christopher Hofmann

Christopher Hofmann is the Director of Medical Writing at Merck, where they specialize in the preparation of ICH-compliant regulatory documents across all phases of clinical development. With experience as a Senior and Principal Medical Writer at Merck, Christopher has also held roles at Affinergy and IQVIA, demonstrating expertise in grant writing and medical documentation. They previously conducted research at Case Western Reserve University, focusing on developing novel treatments for bacterial infections related to cardiovascular devices. Christopher holds both a B.S.E. and a Ph.D. in Biomedical Engineering from Case Western Reserve University.